Alphabet, Inc. (GOOGL, GOOG) stock, which bounced back by 3.2% on Monday after last Friday’s 2% pullback, is on track to ...

Stock Market Today: Dow retakes 45,000 as S&P 500 logs third straight record close on rising trade hopes; Tesla, Alphabet earnings await Investors held onto hopes that the U.S. and Japan’s trade ...

A U.S. judge in San Francisco on Friday rejected a Justice Department request to reverse a decision that allowed Apple Inc and Alphabet Inc's Google to continue to offer Chinese-owned WeChat for ...

A U.S. judge in San Francisco on Thursday said she was "not inclined" to reverse her decision blocking the government from barring Apple Inc and Alphabet Inc's Google from offering WeChat for download ...

Foreign tech companies have issued more euro-denominated debt than expected so far in 2025, driven by attractive funding ...

One in four adults suffer a stroke in their lifetime, leaving around half of them with residual damage such as paralysis or speech impairment because internal bleeding or a lack of oxygen supply kill ...

Standing exercises offer an avenue for reversing aging that cardio can’t match: strength and power. When you train in a standing position, you challenge more muscles at once, demand more stability, ...

Max Fried threw a gem in Game 1 of the AL Wild Card series against the Boston Red Sox. The New York Yankees ace, who will likely finish in the top-3 of the American League Cy Young voting when all is ...

The Trump administration’s shocking cuts in funding for antiterrorism programs in New York will gut crucial NYPD programs that have thwarted planned terror attacks ...

WASHINGTON — President Trump said Tuesday that Harvard University has reached a tentative deal with his administration to restore $2.4 billion in frozen federal grants. America’s oldest college will ...

When we last checked in with how things were looking with the second season of Netflix's Iñaki Godoy (Monkey D. Luffy), Mackenyu (Zoro), Emily Rudd (Nami), Jacob Romero Gibson (Usopp), and Taz Skylar ...

U.S.-based Barinthus Biotherapeutics is entering a reverse merger with U.K. biotech Clywedog Therapeutics, with the combined company expected to advance three clinical assets across diabetes and ...